Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Nutrien Ltd. is a leading global provider of crop inputs and services essential for modern agriculture. The company operates through four key segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. Nutrien Ag Solutions distributes crop nutrients, crop protection products, seeds, and merchandise, while also offering product application, soil and leaf testing, crop scouting, precision agriculture technologies, water management, brokerage agency services, and financing solutions to farmers worldwide. The Potash segment supplies granular and standard potash products, vital for soil fertility. The Nitrogen segment produces ammonia, urea, and environmentally smart nitrogen solutions used in fertilizers. The Phosphate segment delivers phosphate-based fertilizers to support crop growth and yield enhancement. Nutrien Ltd. plays a critical role in the agricultural supply chain by enabling efficient farming practices and sustainable nutrient management across diverse crops and regions. Founded in 2018 and headquartered in Saskatoon, Saskatchewan, Canada, Nutrien Ltd. serves growers, retailers, and agribusinesses globally through its integrated production and distribution network.
$86.51
+$0.57 (+0.66%)
EOD Jun 25, 2026 · Twelve Data
14.39% operating margin is respectable but not wide. ROIC at 7.81%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 3.5%, steady but not accelerating.
Net debt of $11.32B represents 5.7x FCF, leverage limits flexibility.
12.4x earnings, 13.3x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$27.83B
▲ +3.5% YoY
Net Income (TTM)
$2.42B
▲ +228.1% YoY
Op. Margin
14.67%
▲ +3.0pp YoY
ROIC
7.81%
▲ +3.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$2.21B
▲ +45.0% YoY
Op. Cash Flow (TTM)
$5.82B
▲ +31.5% YoY
Net Debt
$11.32B
Cash & Equiv.
$701M
3Y CAGR: -10.8%
3Y CAGR: -29.2%
Continue Research
At a P/E of 12.4 and a price-to-free-cash-flow of 13.3, Nutrien (NTR) trades above a two-stage DCF intrinsic value of about $55.94 per share, so at $86.51 the stock looks overvalued (35.3% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Nutrien scores 23/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 3.6%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $55.94 per share for NTR, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $41.96. At today's $86.51, that puts the stock about 35.3% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Nutrien scores 23 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 14.7% operating margin and a 7.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Nutrien pays a regular dividend of about $2.20 per share per year (typically in quarterly installments), a yield of roughly 3.6% at the current price. That is a payout ratio of about 43.8% of earnings, so the dividend is well covered. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For NTR's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. NTR currently trades above its estimated intrinsic value and scores 23/100 on quality (lower-quality). It also yields about 3.6%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.